Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3–4.5 hours

By Li Bing-Hu   Ding Xin   Yin Yan-Wei   Liu Yun   Gao Chang-Yue   Zhang Li-Li   Li Jing-Cheng  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1105-1114

Informa Healthcare

Access to resources Recommend Favorite

Recurrent Pregnancy Loss and Its Relation to FV Leiden, FII G20210A and Polymorphisms of Plasminogen Activator and Plasminogen Activator Inhibitor

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 3, 2004-06 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

The Safety and Efficacy of Low‐dose Tissue Plasminogen Activator in the Treatment of Systemic Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 9, 1995-09 ,pp. : 637-642

John Wiley & Sons Inc

Access to resources Recommend Favorite